140 related articles for article (PubMed ID: 30138198)
1. First Drug Approved to Reduce Bleeding Risk During Medical Procedures in Patients with Chronic Liver Disease.
Aschenbrenner DS
Am J Nurs; 2018 Sep; 118(9):22. PubMed ID: 30138198
[No Abstract] [Full Text] [Related]
2. Managing periprocedural thrombocytopenia in cirrhosis: aiming for a safety window.
Bissonnette J; Valla D; Rautou PE
J Hepatol; 2014 Dec; 61(6):1199-201. PubMed ID: 25219886
[No Abstract] [Full Text] [Related]
3. Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease.
Xu H; Cai R
Expert Rev Clin Pharmacol; 2019 Sep; 12(9):859-865. PubMed ID: 31352834
[No Abstract] [Full Text] [Related]
4. Second-generation thrombopoietin receptor agonists: New players in the management of cirrhotic patients undergoing therapeutic endoscopy?
Radaelli F; Hassan C; Buscarini E; Dinis-Ribeiro M; Fuccio L
Dig Liver Dis; 2021 Oct; 53(10):1362-1363. PubMed ID: 34088596
[No Abstract] [Full Text] [Related]
5. Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure.
Terrault NA; Hassanein T; Howell CD; Joshi S; Lake J; Sher L; Vargas H; McIntosh J; Tang S; Jenkins TM
J Hepatol; 2014 Dec; 61(6):1253-9. PubMed ID: 25048952
[TBL] [Abstract][Full Text] [Related]
6. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.
Maan R; de Knegt RJ; Veldt BJ
Drugs; 2015 Nov; 75(17):1981-92. PubMed ID: 26501978
[TBL] [Abstract][Full Text] [Related]
7. Lusutrombopag: First Global Approval.
Kim ES
Drugs; 2016 Jan; 76(1):155-8. PubMed ID: 26666417
[TBL] [Abstract][Full Text] [Related]
8. New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations.
Clemons Bankston P; Al-Horani RA
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226783
[TBL] [Abstract][Full Text] [Related]
9. Avatrombopag: First Global Approval.
Shirley M
Drugs; 2018 Jul; 78(11):1163-1168. PubMed ID: 29995177
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia in Chronic Liver Disease: New Management Strategies.
Nilles KM; Flamm SL
Clin Liver Dis; 2020 Aug; 24(3):437-451. PubMed ID: 32620282
[TBL] [Abstract][Full Text] [Related]
11. Relationship between response to lusutrombopag and splenic volume.
Uojima H; Arase Y; Itokawa N; Atsukawa M; Satoh T; Miyazaki K; Hidaka H; Sung JH; Kako M; Tsuruya K; Kagawa T; Iwakiri K; Horie R; Koizumi W
World J Gastroenterol; 2018 Dec; 24(46):5271-5279. PubMed ID: 30581275
[TBL] [Abstract][Full Text] [Related]
12. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura.
Nurden AT; Viallard JF; Nurden P
Lancet; 2009 May; 373(9674):1562-9. PubMed ID: 19324405
[TBL] [Abstract][Full Text] [Related]
13. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T
Exp Hematol; 2008 Oct; 36(10):1337-42. PubMed ID: 18619724
[TBL] [Abstract][Full Text] [Related]
14. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
Terrault N; Chen YC; Izumi N; Kayali Z; Mitrut P; Tak WY; Allen LF; Hassanein T
Gastroenterology; 2018 Sep; 155(3):705-718. PubMed ID: 29778606
[TBL] [Abstract][Full Text] [Related]
15. Lusutrombopag: A Review in Thrombocytopenia in Patients with Chronic Liver Disease Prior to a Scheduled Procedure.
Shirley M; McCafferty EH; Blair HA
Drugs; 2019 Oct; 79(15):1689-1695. PubMed ID: 31529283
[TBL] [Abstract][Full Text] [Related]
16. Prucalopride succinate, Fostamatinib disodium hexahydrate, Avatrombopag maleate, and Lusutrombopag.
Hussar DA; Kludjian GA
J Am Pharm Assoc (2003); 2019; 59(4):601-604. PubMed ID: 31296323
[No Abstract] [Full Text] [Related]
17. Lusutrombopag as pretreatment for liver biopsy following liver transplantation.
Katano T; Sanada Y; Okada N; Mizuta K
Pediatr Int; 2018 Nov; 60(11):1033-1034. PubMed ID: 30375132
[No Abstract] [Full Text] [Related]
18. Lusutrombopag as a substitute for platelet transfusion for thrombocytopenia associated with chronic liver disease in a patient undergoing endoscopic spinal surgery: A case report.
Kaneko T; Takano Y; Ishibashi K
Medicine (Baltimore); 2021 Jan; 100(2):e24094. PubMed ID: 33466174
[TBL] [Abstract][Full Text] [Related]
19. Bleeding events in lusutrombopag-treated thrombocytopenic patients.
Giannini EG; Kano T; Ochiai T; Bentley R; Shrestha P; Afdhal N
Eur J Clin Invest; 2021 Jun; 51(6):e13503. PubMed ID: 33523482
[No Abstract] [Full Text] [Related]
20. Avatrombopag maleate for the treatment of periprocedural thrombocytopenia in patients with chronic liver disease.
Al-Samkari H
Drugs Today (Barc); 2018 Nov; 54(11):647-655. PubMed ID: 30539164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
